Showing the single result

  • Oxlumo lumasiran
    In Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Oxlumo (lumasiran) Online For Sale

    $62,829.90

    DISEASE INDICATIONS: Primary hyperoxaluria type 1 (PH1)

    MANUFACTURER: Alnylam Pharmaceuticals

    USAGE: Subcutaneous

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Oxlumo (lumasiran) is an RNA interference drug that treats primary hyperoxaluria type 1 (PH1) by targeting the liver to reduce oxalate production, which can slow kidney and liver disease progression.

    Select options This product has multiple variants. The options may be chosen on the product page